


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+5.83%
-13.03%
+10.93%
+2.36%
-17.75%
ADMA
ADMA Biologics
$19.14
Strengths

Earnings are forecast to grow

Investors confidence is positive

Upgraded on attractively valued

Outperform the market
Chart
$15.48 (+23.64%)
$16.91 (+13.19%)
$18.34 (+4.36%)
$19.79 (-3.28%)
ADMA has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk

ADMA overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Has been gaining momentum
Activity
Activity

Investors confidence is positive
Future
Future

Earnings are forecast to grow

Outperform the market
![]()
ADMA Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
ADMA Street Sentiment is extremely bullish and have positive views on the near-term outlook
Average key support and resistance price levels.
Login to displayWhat is ADMA current stock price?
What are ADMA stock strengths?
What is ADMA Risk Level?
What is ADMA market cap and volume?
What is ADMA current Stock IQ?
Should I buy ADMA stock right now?
Is ADMA a Strong Buy right now?
What does a 'Strong Buy' rating mean for ADMA?
What does a 'Strong Sell' rating mean for ADMA?
What factors influence ADMA's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+5.83%
-13.03%
+10.93%
+2.36%
-17.75%
ADMA
ADMA Biologics
Current Price
$19.14
Stock Insights
Strengths

Earnings are forecast to grow

Investors confidence is positive

Upgraded on attractively valued

Outperform the market

Chart
$15.48 (+23.64%)
$16.91 (+13.19%)
$18.34 (+4.36%)
$19.79 (-3.28%)
ADMA Analysts Opinion
ADMA Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Has been gaining momentum
Activity
Activity

Investors confidence is positive
Future
Future

Earnings are forecast to grow

Outperform the market
![]()
ADMA Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
ADMA Street Sentiment is extremely bullish and have positive views on the near-term outlook
ADMA has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk

Average key support and resistance price levels.
ADMA Latest Analysis
Adma Biologics (ADMA) Upgraded to Buy: Heres What You Should Know. Adma Biologics (ADMA) has been upgraded to a Zacks Rank #2 (Buy) reflecting growing optimism about the companys earnings prospects. This might drive the stock higher in the near term.
Tue Nov 25, 2025
Adma Biologics (ADMA) Recently Broke Out Above the 200-Day Moving Average. When a stock breaks out above the 200-day simple moving average good things could be on the horizon. How should investors react?
Tue Nov 25, 2025
Is ADMA Biologics (ADMA) Outperforming Other Medical Stocks This Year?. Here is how Adma Biologics (ADMA) and Cronos Group (CRON) have performed compared to their sector so far this year.
Tue Nov 25, 2025
ADMA Crosses Above Key Moving Average Level. In trading on Monday shares of ADMA Biologics Inc (Symbol: ADMA) crossed above their 200 day moving average of $17.84 changing hands as high as $18.44 per share. ADMA Biologics Inc shares are currently trading up about 7.1% on the day. The chart below shows the one year perf
Mon Nov 24, 2025
Wall Street s Look Optimistic About Adma Biologics (ADMA): Should You Buy?. According to the average brokerage recommendation (ABR) one should invest in Adma Biologics (ADMA). It is debatable whether this highly sought-after metric is effective because Wall Street analysts recommendations tend to be overly optimistic. Would it be worth investing in the stock?
Fri Nov 14, 2025
Adma Biologics (ADMA) Crossed Above the 50-Day Moving Average: What That Means for Investors. Is it a good or bad thing when a stock surpasses resistance at the 50-day simple moving average?
Wed Nov 12, 2025
Adma Biologics (ADMA) Just Flashed Golden Cross Signal: Do You Buy?. When a stock breaks out above the 20-day simple moving average good things could be on the horizon. How should investors react?
Wed Nov 12, 2025
Wall Street Analysts Believe Adma Biologics (ADMA) Could Rally 108.5%: Heres is How to Trade. The consensus price target hints at a 108.5% upside potential for Adma Biologics (ADMA). While empirical research shows that this sought-after metric is hardly effective an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Tue Nov 11, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
ADMA Stock trends
ADMA Stock performance
ADMA Stock analysis
ADMA investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.